Great news and new hope!
CIC and the UMMC Covid-19 special taskforce go full force looking for new treatment for Covid-19 patients.
“UMMC has already used tocilizumab (trade name Actemra) on several Covid-19 patients who developed “cytokine storm” syndrome, a dangerous overreaction of the immune system, resulting in respiratory and multi-organ failure and said that the results were encouraging”.
Salam Aidilfitri dari CIC! Semoga Syawal ini diberkati dengan kegembiraan dan keberkatan untuk anda dan seluruh warga keluarga. #LeaderinClinicalResearch#ClinicalInvestigationcentre#ClinicalResearchinMalaysia#ClinicalResearch
21-22 March 2024 – CIC represented by Dr Phan joined the “Expert Consultation on Strengthening Clinical Trials in the Western Pacific” organized by World Health
© CIC. All Rights Reserved. 2024